224 related articles for article (PubMed ID: 24409815)
21. Signaling systems affecting the severity of multiple osteochondromas.
Piombo V; Jochmann K; Hoffmann D; Wuelling M; Vortkamp A
Bone; 2018 Jun; 111():71-81. PubMed ID: 29545125
[TBL] [Abstract][Full Text] [Related]
22. Heparan sulphate biosynthesis and disease.
Nadanaka S; Kitagawa H
J Biochem; 2008 Jul; 144(1):7-14. PubMed ID: 18367479
[TBL] [Abstract][Full Text] [Related]
23. Cell biology of osteochondromas: bone morphogenic protein signalling and heparan sulphates.
Cuellar A; Reddi AH
Int Orthop; 2013 Aug; 37(8):1591-6. PubMed ID: 23771188
[TBL] [Abstract][Full Text] [Related]
24. EXT1 regulates chondrocyte proliferation and differentiation during endochondral bone development.
Hilton MJ; Gutiérrez L; Martinez DA; Wells DE
Bone; 2005 Mar; 36(3):379-86. PubMed ID: 15777636
[TBL] [Abstract][Full Text] [Related]
25. EXT 1 gene mutation induces chondrocyte cytoskeletal abnormalities and defective collagen expression in the exostoses.
Legeai-Mallet L; Rossi A; Benoist-Lasselin C; Piazza R; Mallet JF; Delezoide AL; Munnich A; Bonaventure J; Zylberberg L
J Bone Miner Res; 2000 Aug; 15(8):1489-500. PubMed ID: 10934647
[TBL] [Abstract][Full Text] [Related]
26. Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus.
Kobayashi S; Morimoto K; Shimizu T; Takahashi M; Kurosawa H; Shirasawa T
Biochem Biophys Res Commun; 2000 Feb; 268(3):860-7. PubMed ID: 10679296
[TBL] [Abstract][Full Text] [Related]
27. Compound heterozygous loss of Ext1 and Ext2 is sufficient for formation of multiple exostoses in mouse ribs and long bones.
Zak BM; Schuksz M; Koyama E; Mundy C; Wells DE; Yamaguchi Y; Pacifici M; Esko JD
Bone; 2011 May; 48(5):979-87. PubMed ID: 21310272
[TBL] [Abstract][Full Text] [Related]
28. The putative tumour suppressor EXT1 alters the expression of cell-surface heparan sulfate.
McCormick C; Leduc Y; Martindale D; Mattison K; Esford LE; Dyer AP; Tufaro F
Nat Genet; 1998 Jun; 19(2):158-61. PubMed ID: 9620772
[TBL] [Abstract][Full Text] [Related]
29. Reevaluation of a genetic model for the development of exostosis in hereditary multiple exostosis.
Hall CR; Cole WG; Haynes R; Hecht JT
Am J Med Genet; 2002 Sep; 112(1):1-5. PubMed ID: 12239711
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome and genotype in patients with hereditary multiple exostoses.
Jäger M; Westhoff B; Portier S; Leube B; Hardt K; Royer-Pokora B; Gossheger G; Krauspe R
J Orthop Res; 2007 Dec; 25(12):1541-51. PubMed ID: 17676624
[TBL] [Abstract][Full Text] [Related]
31. Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter.
de Andrea CE; Hogendoorn PC
J Pathol; 2012 Jan; 226(2):219-28. PubMed ID: 21956842
[TBL] [Abstract][Full Text] [Related]
32. Hereditary multiple and isolated sporadic exostoses in the same kindred: identification of the causative gene (EXT2) and detection of a new mutation, nt112delAT, that distinguishes the two phenotypes.
Vujic M; Bergman A; Romanus B; Wahlström J; Martinsson T
Int J Mol Med; 2004 Jan; 13(1):47-52. PubMed ID: 14654969
[TBL] [Abstract][Full Text] [Related]
33. Association of autism in two patients with hereditary multiple exostoses caused by novel deletion mutations of EXT1.
Li H; Yamagata T; Mori M; Momoi MY
J Hum Genet; 2002; 47(5):262-5. PubMed ID: 12032595
[TBL] [Abstract][Full Text] [Related]
34. Abnormal scarring with keloid formation after osteochondroma excision in children with multiple hereditary exostoses.
Hosalkar H; Greenberg J; Gaugler RL; Garg S; Dormans JP
J Pediatr Orthop; 2007; 27(3):333-7. PubMed ID: 17414021
[TBL] [Abstract][Full Text] [Related]
35. Novel EXT1 mutation identified in a pedigree with hereditary multiple exostoses.
Cao L; Liu F; Kong M; Fang Y; Gu H; Chen Y; Zhao C; Zhang S; Bi Q
Oncol Rep; 2014 Feb; 31(2):713-8. PubMed ID: 24297320
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA profiling of multiple osteochondromas: identification of disease-specific and normal cartilage signatures.
Zuntini M; Salvatore M; Pedrini E; Parra A; Sgariglia F; Magrelli A; Taruscio D; Sangiorgi L
Clin Genet; 2010 Dec; 78(6):507-16. PubMed ID: 20662852
[TBL] [Abstract][Full Text] [Related]
37. Interactions of signaling proteins, growth factors and other proteins with heparan sulfate: mechanisms and mysteries.
Billings PC; Pacifici M
Connect Tissue Res; 2015; 56(4):272-80. PubMed ID: 26076122
[TBL] [Abstract][Full Text] [Related]
38. A novel deletion mutation of the EXT2 gene in a large Chinese pedigree with hereditary multiple exostosis.
Xiao CY; Wang J; Zhang SZ; Van Hul W; Wuyts W; Qiu WM; Wu H; Zhang G
Br J Cancer; 2001 Jul; 85(2):176-81. PubMed ID: 11461073
[TBL] [Abstract][Full Text] [Related]
39. Severity of disease and risk of malignant change in hereditary multiple exostoses. A genotype-phenotype study.
Porter DE; Lonie L; Fraser M; Dobson-Stone C; Porter JR; Monaco AP; Simpson AH
J Bone Joint Surg Br; 2004 Sep; 86(7):1041-6. PubMed ID: 15446535
[TBL] [Abstract][Full Text] [Related]
40. Defective chondrocyte proliferation and differentiation in osteochondromas of MHE patients.
Benoist-Lasselin C; de Margerie E; Gibbs L; Cormier S; Silve C; Nicolas G; LeMerrer M; Mallet JF; Munnich A; Bonaventure J; Zylberberg L; Legeai-Mallet L
Bone; 2006 Jul; 39(1):17-26. PubMed ID: 16476576
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
